Key sentence from the paper: “The addition of radiotherapy to ADT for patients with locally advanced prostate cancer significantly improved overall survival and had only modest and transient negative impact on relevant domains of health-related quality of life [outcomes].”
Read MoreDoes prostate cancer progress faster for advanced patients with diabetes on ADT?
Key sentence from the paper: “Diabetes mellitus may have a detrimental effect on progression of advanced prostate cancer, particularly in those patients with radiographic evidence of metastases.”
Read MoreWith over-prescribing ADT in the US, are all patients treated equally?
Key sentence from the paper: “Increased age, greater comorbidity, being in a racial/ethnic minority, high primary care utilization in the prior year and receiving a radiation oncology consultation before treatment were associated with increased odds of gonadotropin releasing hormone agonist overuse.”
Read MoreEthnic difference may exist in the efficacy and adverse effects of ADT
Key sentence from the paper: “In terms of adverse effects, including bone loss, cardiovascular risk, and other factors, ADT appeared to be better tolerated in Japanese than Western populations.”
Read MoreYet again, ADT is linked to metabolic syndrome and diabetes
Key sentence from the paper: “The results [of this study] suggest a 75% increased risk of metabolic syndrome and a 36% increased risk of diabetes following ADT for men with prostate cancer.”
Read MoreDoes a healthy lifestyle help for patients already on ADT?
Key sentence from the paper: “A 6-month diet and physical activity intervention can minimize the adverse body composition changes associated with ADT.”
Read MoreWhen is it beneficial to add chemotherapy to ADT plus radiotherapy?
Key sentence from the paper: “[This study] found no statistically significant difference in the outcome of overall survival, biochemical failure, local progression, distant metastasis or disease-free survival with the addition of chemotherapy using oral etoposide to a regimen of 2 years of androgen suppression + radiation therapy.”
Read MoreAre there certain populations that benefit from ADT as a primary treatment?
Key sentence from the paper: “[T]here is no increase in the mortality of men treated with [primary androgen deprivation therapy].
Read MoreDo the newer agents for ADT add to the cardiovascular risk of the LHRH drugs?
Key sentence from the paper: “[O]ur analysis reported a significant increase in cardiac events and hypertension in [metastatic castrate resistant prostate cancer] patients treated with new hormonal therapies.”
Read MoreAre there racial differences in the risk of fractures for patients on ADT?
Key sentence from the paper: “ADT with GnRH agonists or orchiectomy increases the risk of fracture in Chinese patients with prostate cancer. However, the magnitude of the increase in risk is seemingly not as large as that in Western populations.”
Read More